Skip to main content

Advertisement

Log in

Clinical-diffusion mismatch defined by NIHSS and ASPECTS in non-lacunar anterior circulation infarction

Journal of Neurology Aims and scope Submit manuscript

Abstract

Objectives Instead of the mismatch in MRI between the perfusion-weighted imaging (PWI) lesion and the smaller diffusion-weighted imaging (DWI) lesion (PWI-DWI mismatch), clinical-DWI mismatch (CDM) has been proposed as a new diagnostic marker of brain tissue at risk of infarction in acute ischemic stroke. The Alberta Stroke Program Early CT Score (ASPECTS) has recently been applied to detect early ischemic change of acute ischemic stroke. The present study applies the CDM concept to DWI data and investigated the utility of the CDM defined by the NIH Stroke Scale (NIHSS) and ASPECTS in patients with non-lacunar anterior circulation infarction. Methods Eighty-seven patients with first ever ischemic stroke within 24 hours of onset with symptoms of non-lacunar anterior circulation infarction with the NIHSS score ≥ 8 were enrolled. Initial lesion extent was measured by the ASPECTS on DWI within 24 hours, and initial neurological score was measured by the NIHSS. As NIHSS ≥ 8 has been suggested as a clinical indicator of a large volume of ischemic brain tissue, and the majority of patients with non-lacunar anterior infarction with score of NIHSS < 8 had lesions with ASPECTS ≥ 8 on DWI, so CDM was defined as NIHSS ≥ 8 and DWI-ASPECTS 8 ≥ . We divided patients into matched and mismatched patient groups, and compared them with respect to background characteristics, neurological findings, laboratory data, radiological findings and outcome. Results There were 35 CDM-positive patients (P group, 40.2%) and 52 CDM-negative patients (N group , 59.8%). P group patients had a higher risk of early neurological deterioration (END) than N group patients (37.1% vs 13.5%, p < 0.05), which were always accompanied by lesion growth defined by 2 or more points decrease on ASPECTS (36 to 72 hours after onset on CT). The NIHSS at entry were significantly lower in the P group, but there was no difference in the outcome at three months measured by the modified Rankin Scale. However, CDM was not an independent predictor of END by multiple logistic regression analysis. Conclusions Patients with CDM had high rate of early neurological deterioration and lesion growth. CDM defined as NIHSS ≥ 8 and DWI-ASPECTS ≥ 8 can be another marker for detecting patients with tissue at risk of infarction, but more work is needed to clarify whether this CDM method is useful in acute stroke management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587

    Article  Google Scholar 

  2. Molina CA, Saver JL. Extending reperfusion therapy for acute ischemic stroke (2005) Emerging pharmacological, mechanical, and imaging strategies. Stroke 36:2311–2320

    Article  PubMed  Google Scholar 

  3. Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT, Wechsler LR, Roberts HC, Dillon WP, Fischbein NJ, Firszt CM, Schulz GA, Buchan AM, for the PROACT-II Investigators (2003) Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 34:1925–1931

    Article  PubMed  Google Scholar 

  4. Dávalos A, Blanco M, Pedraza S, Leira R, Castellanos M, Pumar JM, Silva Y, Serena J, Castillo J (2004) The clinical-DWI mismatch. A new diagnostic approach to the brain tissue at risk of infarction. Neurology 62:2187–2192

    Google Scholar 

  5. Sobesky J, Weber OZ, Lehnhardt F-G, Hesselmann V, Neveling M, Jacobs A, Heiss W-D (2005) Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke 36:980–985

    Article  PubMed  Google Scholar 

  6. Hillis AE, Wityk RJ, Barker PB, Ulatowski JA, Jacobs MA (2003) Changes in perfusion in acute nondominant hemisphere stroke may be better estimated by tests of hemispatial neglect than by the National Institutes of Health Stroke Scale. Stroke 34:2392–2398

    Article  PubMed  Google Scholar 

  7. Prosser J, Butcher K, Allport L, Parsons M, MacGregor L, Desmond P, Tress B, Davis S (2005) Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke 36:1700–1704

    Article  PubMed  Google Scholar 

  8. Reineck LA, Agarwal S, Hillis AE (2005) “Diffusion-clinical mismatch” is associated with potential for early recovery of aphasia. Neurology 64:828–833

    PubMed  Google Scholar 

  9. Barber PA, Demchuk AM, Zhang J, Buchan AM, for the ASPECTS Study Group (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 355:1670–1674

    Article  PubMed  CAS  Google Scholar 

  10. The National Institute of Neurological Disorders, Stroke (NINDS) rt-PA Stroke Study Group (2000) Effects of intravenous recombinant tissue plasminogen activator on ischemic lesion size measured by computed tomography. Stroke 31:2912–2919

    Google Scholar 

  11. Demchuk AM, Hill MD, Barber PA, Silver B, Patel SC, Levine SR, for the NINDS rtPA Stroke Study Group (2005) Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke 36:2110–2115

    Article  PubMed  Google Scholar 

  12. Barber PA, Hill MD, Eliasziw M, Demchuk AM, Pexman JHW, Hudon ME, Tamanek A, Frayne R, Buchan AM, for the ASPECTS Study Group (2005) Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry 76:1528–1533

    Article  PubMed  CAS  Google Scholar 

  13. DeGraba TJ, Hallenbeck JM, Pettigrew KD, Dutka AJ, Kelly BJ (1999) Progression in acute stroke: value of the initial NIH Stroke Scale score on patient stratification in future trials. Stroke 30:1208–1212

    PubMed  CAS  Google Scholar 

  14. Tong DC, Yenari MA, Albers GW, O’Brien M, Marks MP, Moseley ME (1998) Correlation of perfusion- and diffusion- weighted MRI with NIHSS score in acute ( < 6.5 hours) ischemic stroke. Neurology 50:864–870

    PubMed  CAS  Google Scholar 

  15. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU (2001) Epidemiology of ischemic stroke subtypes according to TOAST criteria. Incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 32:2735–2740

    PubMed  CAS  Google Scholar 

  16. Tei H, Uchiyama S, Ohara K, Kobayashi M, Uchiyama Y, Fukuzawa M (2000) Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project. Stroke 31:2049–2054

    PubMed  CAS  Google Scholar 

  17. Toyoda K, Fujii K, Kamouchi M, Nakane H, Arihiro S, Okada Y, Ibayashi S, Iida M (2004) Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion. J Neurol Sci 221:11–17

    Article  PubMed  CAS  Google Scholar 

  18. Darby DG, Barber PA, Gerraty RP, Desmond PM, Yang Q, Parsons M, Li T, Tress BM, Davis SM (1999) Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke 30:2043–2052

    PubMed  CAS  Google Scholar 

  19. Kent DM, Hill MD, Ruthazer R, Coutts SB, Demchuk AM, Drialowski I, Wunderlich O, von Kummer R (2005) “Clinical-CT mismatch” and the response to systemic thrombolytic therapy in acute ischemic stroke. Stroke 36:1695–1699

    Article  PubMed  CAS  Google Scholar 

  20. Guadagno JV, Warburton EA, Jones PS, Fryer TD, Day DJ, Gillard JH, Carpenter TA, Aigbirhio FI, Price CJ, Baron J-C (2005) The diffusion-weighted lesion in acute stroke: heterogeneous patterns of flow/metabolism uncoupling as assessed by quantitative positron emission tomography. Cerebrovasc Dis 19:239–246

    Article  PubMed  Google Scholar 

  21. Lansberg MG, Thijs VN, Bammer R, Wechsler LR, O’Donnell MJ, Olshen RA, Wijman CA, Kemp SM, Albers GW (2005) Who is most likely to benefit from tPA? The perfusion-diffusion and clinical-diffusion mismatch models disagree. Stroke 36:437

    Google Scholar 

  22. Tei H, Uchiyama S, Usui T (2006) Predictors of good prognosis in total anterior circulation infarction within 6 h after onset under conventional therapy. Acta Neurol Scand 113:301–306

    Article  PubMed  CAS  Google Scholar 

  23. Hacke WH, Albers G, Al-Rawi Y, Bogousslavsky J, Dávalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soengen M, Warach S, for the DIAS Study Group (2005) The desmoteplase in Acute Ischemic Stroke Trial (DIAS). A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36:66–73

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Drs, Kenji Koshimizu, Miyuki Matsumura, Fumiko Koike, Hiroshi Yoshizawa, Yumiko Uchiyama, Etsuko Nishizawa, Megumi Fukuzawa for their clinical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Tei.

Additional information

Received in revised form: 30 July 2006

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tei, H., Uchiyama, S. & Usui, T. Clinical-diffusion mismatch defined by NIHSS and ASPECTS in non-lacunar anterior circulation infarction. J Neurol 254, 340–346 (2007). https://doi.org/10.1007/s00415-006-0368-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-0368-8

Keywords

Navigation